Literature DB >> 35477674

CRRT Fluid Choices: A Solution for a Common Problem?

Anitha Vijayan1.   

Abstract

Entities:  

Keywords:  CRRT; continuous renal replacement therapy; hypophosphatemia; respiratory failure

Mesh：

Substances：

Year:  2022        PMID： 35477674      PMCID： PMC9269581          DOI： 10.2215/CJN.03390322

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  11 in total

1.  Phosphate balance with continuous renal replacement therapy: a simple solution.

Authors:  Swapnil Hiremath; Sharon Slivar; Peter Magner
Journal:  Am J Kidney Dis       Date:  2013-09       Impact factor: 8.860

Review 2.  Prevention of hypophosphatemia during continuous renal replacement therapy-An overlooked problem.

Authors:  Michael Heung; Bruce A Mueller
Journal:  Semin Dial       Date:  2018-02-05       Impact factor: 3.455

3.  Intensity of continuous renal-replacement therapy in critically ill patients.

Authors:  Rinaldo Bellomo; Alan Cass; Louise Cole; Simon Finfer; Martin Gallagher; Serigne Lo; Colin McArthur; Shay McGuinness; John Myburgh; Robyn Norton; Carlos Scheinkestel; Steve Su
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

4.  Preparation times and costs for various solutions used for continuous renal replacement therapy.

Authors:  Alexander R Shaw; Weerachai Chaijamorn; John S Clark; Bruce A Mueller
Journal:  Am J Health Syst Pharm       Date:  2018-06-01       Impact factor: 2.637

5.  Euglycemic ketoacidosis, a common and underecognized complication of continuous renal replacement therapy using glucose-free solutions.

Authors:  Maxime Coutrot; Guillaume Hékimian; Thibaut Moulin; Nicolas Bréchot; Matthieu Schmidt; Sébastien Besset; Ania Nieszkowska; Guillaume Franchineau; Simon Bourcier; Olivier Bourron; Charles-Edouard Luyt; Alain Combes
Journal:  Intensive Care Med       Date:  2018-03-13       Impact factor: 17.440

6.  Reductions in red blood cell 2,3-diphosphoglycerate concentration during continuous renal replacment therapy.

Authors:  Shilpa Sharma; Carlo Brugnara; Rebecca A Betensky; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-23       Impact factor: 8.237

7.  Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy.

Authors:  Melissa L Thompson Bastin; Arnold J Stromberg; Sethabhisha N Nerusu; Lucas J Liu; Kirby P Mayer; Kathleen D Liu; Sean M Bagshaw; Ron Wald; Peter E Morris; Javier A Neyra
Journal:  Clin J Am Soc Nephrol       Date:  2022-04-27       Impact factor: 10.614

Review 8.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

9.  Intensity of renal support in critically ill patients with acute kidney injury.

Authors:  Paul M Palevsky; Jane Hongyuan Zhang; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Devasmita Choudhury; Kevin Finkel; John A Kellum; Emil Paganini; Roland M H Schein; Mark W Smith; Kathleen M Swanson; B Taylor Thompson; Anitha Vijayan; Suzanne Watnick; Robert A Star; Peter Peduzzi
Journal:  N Engl J Med       Date:  2008-05-20       Impact factor: 91.245

10.  Association of Phosphate Containing Solutions with Incident Hypophosphatemia in Critically Ill Patients Requiring Continuous Renal Replacement Therapy.

Authors:  Melissa L Thompson Bastin; Paul M Adams; Sethabhisha Nerusu; Peter E Morris; Kirby P Mayer; Javier A Neyra
Journal:  Blood Purif       Date:  2021-04-29       Impact factor: 2.614
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.